AI assistant
Vericel Corp — Director's Dealing 2025
Feb 24, 2025
31799_dirs_2025-02-24_c190452e-4a4f-4069-bf44-6f7a6b788257.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2025-02-20
Reporting Person: Mara Joseph Anthony Jr (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-20 | Stock Option (Right to Buy) | $54.31 | A | 46250 | Acquired | 2035-02-20 | Common Stock (46250) | Direct |
| 2025-02-20 | Restricted Stock Unit | $ | A | 18500 | Acquired | Common Stock (18500) | Direct |
Footnotes
F1: These options shall begin vesting on February 20, 2025 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F3: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 20, 2026. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively.
F4: No expiration date for this type of award.